Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy

OBJECTIVE: To investigate the safety and efficacy of rituximab in multiple sclerosis (MS). METHODS: In this retrospective uncontrolled observational multicenter study, off-label rituximab-treated patients with MS were identified through the Swedish MS register. Outcome data were collected from the M...

Descripción completa

Detalles Bibliográficos
Autores principales: Salzer, Jonatan, Svenningsson, Rasmus, Alping, Peter, Novakova, Lenka, Björck, Anna, Fink, Katharina, Islam-Jakobsson, Protik, Malmeström, Clas, Axelsson, Markus, Vågberg, Mattias, Sundström, Peter, Lycke, Jan, Piehl, Fredrik, Svenningsson, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109942/
https://www.ncbi.nlm.nih.gov/pubmed/27760868
http://dx.doi.org/10.1212/WNL.0000000000003331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109942/
https://www.ncbi.nlm.nih.gov/pubmed/27760868
http://dx.doi.org/10.1212/WNL.0000000000003331

Ejemplares similares